MedRx Co., Ltd (TYO:4586)
Japan · Delayed Price · Currency is JPY 89.00
-10.00 (-10.10%)
Sep 18, 2025, 3:30 PM JST
MedRx Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2 | - | 7 | 9 | 8 | 15 | Upgrade |
Other Revenue | 42 | 257 | 22 | 50 | - | 100 | Upgrade |
| 44 | 257 | 29 | 59 | 8 | 115 | Upgrade | |
Revenue Growth (YoY) | -82.68% | 786.21% | -50.85% | 637.50% | -93.04% | -31.95% | Upgrade |
Cost of Revenue | 1 | - | 3 | 3 | 2 | 4 | Upgrade |
Gross Profit | 43 | 257 | 26 | 56 | 6 | 111 | Upgrade |
Selling, General & Admin | 463 | 203 | 221 | 232 | 270 | 271 | Upgrade |
Research & Development | 846 | 846 | 737 | 921 | 794 | 967 | Upgrade |
Operating Expenses | 1,310 | 1,050 | 960 | 1,157 | 1,067 | 1,207 | Upgrade |
Operating Income | -1,267 | -793 | -934 | -1,101 | -1,061 | -1,096 | Upgrade |
Interest Expense | - | - | - | - | -1 | - | Upgrade |
Currency Exchange Gain (Loss) | -21 | -1 | 11 | -3 | 1 | -3 | Upgrade |
Other Non Operating Income (Expenses) | -6 | 40 | -7 | -8 | -12 | -18 | Upgrade |
EBT Excluding Unusual Items | -1,294 | -754 | -930 | -1,112 | -1,073 | -1,117 | Upgrade |
Gain (Loss) on Sale of Investments | -68 | -68 | - | - | - | - | Upgrade |
Other Unusual Items | - | 20 | - | 2 | 15 | 11 | Upgrade |
Pretax Income | -1,362 | -802 | -930 | -1,110 | -1,058 | -1,106 | Upgrade |
Income Tax Expense | 12 | 4 | 2 | 1 | 1 | 8 | Upgrade |
Net Income | -1,374 | -806 | -932 | -1,111 | -1,059 | -1,114 | Upgrade |
Net Income to Common | -1,374 | -806 | -932 | -1,111 | -1,059 | -1,114 | Upgrade |
Shares Outstanding (Basic) | 48 | 43 | 35 | 25 | 21 | 16 | Upgrade |
Shares Outstanding (Diluted) | 48 | 43 | 35 | 25 | 21 | 16 | Upgrade |
Shares Change (YoY) | 23.37% | 24.99% | 37.12% | 18.76% | 31.47% | 35.01% | Upgrade |
EPS (Basic) | -28.69 | -18.54 | -26.80 | -43.80 | -49.58 | -68.57 | Upgrade |
EPS (Diluted) | -28.69 | -18.54 | -26.80 | -43.80 | -49.58 | -68.57 | Upgrade |
Free Cash Flow | -1,239 | -803 | -913 | -1,074 | -925 | -1,024 | Upgrade |
Free Cash Flow Per Share | -25.87 | -18.47 | -26.25 | -42.34 | -43.31 | -63.03 | Upgrade |
Gross Margin | 97.73% | 100.00% | 89.66% | 94.92% | 75.00% | 96.52% | Upgrade |
Operating Margin | -2879.55% | -308.56% | -3220.69% | -1866.10% | -13262.50% | -953.04% | Upgrade |
Profit Margin | -3122.73% | -313.62% | -3213.79% | -1883.05% | -13237.50% | -968.70% | Upgrade |
Free Cash Flow Margin | -2815.91% | -312.45% | -3148.28% | -1820.34% | -11562.50% | -890.44% | Upgrade |
EBITDA | -1,241 | -755 | -889 | -1,055 | -1,001 | -1,041 | Upgrade |
EBITDA Margin | - | -293.77% | - | - | - | - | Upgrade |
D&A For EBITDA | 26 | 38 | 45 | 46 | 60 | 55 | Upgrade |
EBIT | -1,267 | -793 | -934 | -1,101 | -1,061 | -1,096 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.